v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2024 $ 47 $ 317 $ 367,828 $ 232,089 $ 12,517 $ 612,798
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       (21,157)   (21,157)
Stock Repurchase     (37)     (37)
Vested Restricted Stock and Performance Shares   1 (1,035)     (1,034)
Stock Issuance to Directors     490     490
Stock Issuance, Net of Equity Issuance Costs     (75)     (75)
Stock Issuance, Settlement of 2025 Notes   11 21,037     21,048
Stock-Based Compensation Expense     1,795     1,795
Preferred Stock Dividends Declared for the Period       (3,756)   (3,756)
Common Stock Dividends Declared for the Period       (24,814)   (24,814)
Other Comprehensive Income (Loss)         (11,196) (11,196)
Balance at Jun. 30, 2025 47 329 390,003 182,362 1,321 574,062
Balance at Dec. 31, 2024 47 317 367,828 232,089 12,517 612,798
Balance at Dec. 31, 2025 47 324 382,494 184,886 (405) 567,346
Balance at Mar. 31, 2025 47 318 368,000 220,272 5,246 593,883
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       (23,418)   (23,418)
Stock Repurchase     (37)     (37)
Stock Issuance to Directors     89     89
Stock Issuance, Settlement of 2025 Notes   11 21,037     21,048
Stock-Based Compensation Expense     914     914
Preferred Stock Dividends Declared for the Period       (1,878)   (1,878)
Common Stock Dividends Declared for the Period       (12,614)   (12,614)
Other Comprehensive Income (Loss)         (3,925) (3,925)
Balance at Jun. 30, 2025 47 329 390,003 182,362 1,321 574,062
Balance at Dec. 31, 2025 47 324 382,494 184,886 (405) 567,346
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       21,317   21,317
Vested Restricted Stock and Performance Shares   2 (1,251)     (1,249)
Stock Issuance to Directors     450     450
Stock Issuance, Net of Equity Issuance Costs   49 97,409     97,458
Stock-Based Compensation Expense     2,032     2,032
Preferred Stock Dividends Declared for the Period       (3,756)   (3,756)
Common Stock Dividends Declared for the Period       (26,891)   (26,891)
Other Comprehensive Income (Loss)         6,476 6,476
Balance at Jun. 30, 2026 47 375 481,134 175,556 6,071 663,183
Balance at Mar. 31, 2026 47 333 396,749 176,442 1,792 575,363
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       15,112   15,112
Stock Issuance to Directors     69     69
Stock Issuance, Net of Equity Issuance Costs   42 83,289     83,331
Stock-Based Compensation Expense     1,027     1,027
Preferred Stock Dividends Declared for the Period       (1,878)   (1,878)
Common Stock Dividends Declared for the Period       (14,120)   (14,120)
Other Comprehensive Income (Loss)         4,279 4,279
Balance at Jun. 30, 2026 $ 47 $ 375 $ 481,134 $ 175,556 $ 6,071 $ 663,183